Indocyanine green (lCG) is a near-infrared fluorescent dye, and protein-bound ICGcan be excited by external light with a wavelength range of 750 ~ 810 nm, and emitsnear-infrared light with a wavelength of about 840nm. its half-life in blood is about 3 ~ 5minutes, After entering the blood and binding to protein, it is absorbed by liver cells,then enters the intestine through biliary tract, and finally is excreted with feces.

The indocyanine green injection has passed the double consistency evaluation by Akorn in the United States and Daiichi Sankyo in Japan. With its high purity, low impurity content and optimized storage conditions, lCG has brought more stable and reliable diagnosis and treatment options to the medical community.

Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors and retinal vascular lesions; Intraoperative staining of capsule and internal limiting membrane.

Advantages: Provides clear choroidal vascular images for accurate diagnosis. In surgery, fluorescent staining helps identify the capsule and internal limiting membrane more accurately.

Indications: Evaluation of liver reserve function, liver tumor image development, liver segment identification, and bile leakage observation.

Advantages: Rapid, accurate, and safe method to evaluate liver reserve. Helps physicians identify liver structures more clearly to improve surgical safety.

Indications: Accurate localization of tumors, image development of lymphatic system, and assessment of blood supply.

Advantages: The fluorescence signal makes it intuitive to judge the target, enhancing visibility during operations.

Product range includes the research, development, production, and sales of high-end medical devices (such as the fluorescence imaging series), fluorescence contrast agent drugs (such as ICG, the targeted contrast agent series, etc.), and core components (such as the fluorescence CMOS camera module, endoscope, etc.), providing customers with a full-chain solution. The series of products have been used in more than 500 large hospitals.

Focus is placed on core technologies such as molecular fluorescence, Raman spectroscopy, AI, computer-aided drug molecular design (CADD), and AI-assisted drug design. The mission is to become a global leader in molecular fluorescence technology through the synergy of medical devices and pharmaceuticals.

Holding 131 core invention patents and multiple US invention patents, the enterprise has undertaken numerous national and provincial key research projects. As a strategic partner of international leading companies in Germany and Japan, cooperative business has been established in more than 10 overseas countries.